NO20005217D0 - DNA som koder for strukturelt protein-1 i infeksiøs lakseanemivirus og anvendelse derav - Google Patents

DNA som koder for strukturelt protein-1 i infeksiøs lakseanemivirus og anvendelse derav

Info

Publication number
NO20005217D0
NO20005217D0 NO20005217A NO20005217A NO20005217D0 NO 20005217 D0 NO20005217 D0 NO 20005217D0 NO 20005217 A NO20005217 A NO 20005217A NO 20005217 A NO20005217 A NO 20005217A NO 20005217 D0 NO20005217 D0 NO 20005217D0
Authority
NO
Norway
Prior art keywords
structural protein
dna encoding
infectious salmon
anemia virus
protein
Prior art date
Application number
NO20005217A
Other languages
English (en)
Other versions
NO20005217L (no
NO330866B1 (no
Inventor
Eirik E Biering
Bjoern B Krossoey
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20005217(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20005217D0 publication Critical patent/NO20005217D0/no
Publication of NO20005217L publication Critical patent/NO20005217L/no
Publication of NO330866B1 publication Critical patent/NO330866B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20005217A 1999-10-18 2000-10-17 Peptid, vaksine, diagnostisk sett samt anvendelse av en nukleotidsekvens NO330866B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99203401 1999-10-18

Publications (3)

Publication Number Publication Date
NO20005217D0 true NO20005217D0 (no) 2000-10-17
NO20005217L NO20005217L (no) 2001-04-19
NO330866B1 NO330866B1 (no) 2011-08-01

Family

ID=8240749

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005217A NO330866B1 (no) 1999-10-18 2000-10-17 Peptid, vaksine, diagnostisk sett samt anvendelse av en nukleotidsekvens

Country Status (10)

Country Link
US (1) US6471964B1 (no)
EP (1) EP1094069B2 (no)
JP (1) JP4777508B2 (no)
AT (1) ATE286507T1 (no)
AU (1) AU778791B2 (no)
CA (1) CA2321437A1 (no)
DE (1) DE60017229D1 (no)
DK (1) DK1094069T4 (no)
NO (1) NO330866B1 (no)
NZ (1) NZ507530A (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1200132E (pt) * 1999-08-07 2006-11-30 Novartis Ag Sequências de ácidos nucleicos e de aminoácidos do vírus da anemia infecciosa do salmão e sua utilização como vacinas
CA2402339C (en) * 2000-03-08 2010-01-12 The University Court Of The University Of Aberdeen Viral antigen and vaccine against isav (infectious salmon anaemia virus)
CA2393895A1 (en) * 2001-07-17 2003-01-17 University Of Prince Edward Island Serological test for isav in fish
ATE505482T1 (de) * 2001-10-19 2011-04-15 Intervet Int Bv Impfstoff gegen infektiöses lachsanämievirus
US7317142B2 (en) 2002-12-13 2008-01-08 Prodi Gene, Inc. Immunization of fish with plant-expressed recombinant proteins
US8753878B2 (en) 2006-12-22 2014-06-17 Ewos S.A. Process and formulation for immunizing fish in aquaculture systems
US9366667B2 (en) 2009-10-02 2016-06-14 The Trustees Of Columbia University In The City Of New York Piscine reovirus diagnostic compositions
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1200110A (zh) * 1995-10-18 1998-11-25 拜尔公司 亚氨基乙酰胺类化合物
ES2268719T3 (es) * 1996-11-04 2007-03-16 Ottawa Health Research Institute Procedimiento de expresion de polipeptidos en peces por inmersion en una solucion de plasmidos de adn.
KR20010032336A (ko) * 1997-11-21 2001-04-16 브랑디 빠스깔 클라미디아 뉴모니아 게놈 서열과 폴리펩티드, 이의 단편및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
PT1200132E (pt) * 1999-08-07 2006-11-30 Novartis Ag Sequências de ácidos nucleicos e de aminoácidos do vírus da anemia infecciosa do salmão e sua utilização como vacinas

Also Published As

Publication number Publication date
CA2321437A1 (en) 2001-04-18
NO20005217L (no) 2001-04-19
NO330866B1 (no) 2011-08-01
AU6653800A (en) 2001-04-26
AU778791B2 (en) 2004-12-23
EP1094069A1 (en) 2001-04-25
DK1094069T4 (da) 2008-07-21
EP1094069B2 (en) 2008-04-23
JP2001211888A (ja) 2001-08-07
NZ507530A (en) 2001-08-31
DK1094069T3 (da) 2005-05-17
US6471964B1 (en) 2002-10-29
DE60017229D1 (de) 2005-02-10
EP1094069B1 (en) 2005-01-05
ATE286507T1 (de) 2005-01-15
JP4777508B2 (ja) 2011-09-21

Similar Documents

Publication Publication Date Title
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CA2005291A1 (en) Feline infectious peritonitis virus diagnostic tools
ATE329616T1 (de) Virale nukleotidsequenz vr-2332 und nutzungsverfahren
DE60144201D1 (de) Lawsonia intracellularis Impfstoff
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
NO20005217L (no) DNA som koder for strukturelt protein-1 i infeksiös lakseanemivirus og anvendelse derav
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
WO2001021807A8 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
NO885090L (no) Polypeptider.
ATE332712T1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
WO2001049712A3 (en) Vaccine against isav (infectious salmon anaemia virus)
DE3853693D1 (de) DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung.
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
NO20041564L (no) Infeksios lakse anemi-virus vaksine
WO2002026784A3 (en) Matrix proteins m1 and m2 of infections salmon anaemia virus
WO2002095413A3 (en) Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees